Found: 13
Select item for more details and to access through your institution.
Elevated serum B-cell activator factor levels predict rapid progressive interstitial lung disease in anti-melanoma differentiation associated protein 5 antibody positive dermatomyositis.
- Published in:
- Orphanet Journal of Rare Diseases, 2024, v. 19, p. 1, doi. 10.1186/s13023-024-03153-6
- By:
- Publication type:
- Article
Rapidly progressive interstitial lung disease risk prediction in anti-MDA5 positive dermatomyositis: the CROSS model.
- Published in:
- Frontiers in Immunology, 2024, p. 1, doi. 10.3389/fimmu.2024.1286973
- By:
- Publication type:
- Article
Identification of Three Different Phenotypes in Anti–Melanoma Differentiation–Associated Gene 5 Antibody–Positive Dermatomyositis Patients: Implications for Prediction of Rapidly Progressive Interstitial Lung Disease.
- Published in:
- Arthritis & Rheumatology, 2023, v. 75, n. 4, p. 609, doi. 10.1002/art.42308
- By:
- Publication type:
- Article
Time-dependent changes in RPILD and mortality risk in anti-MDA5+ DM patients: a cohort study of 272 cases in China.
- Published in:
- Rheumatology, 2023, v. 62, n. 3, p. 1216, doi. 10.1093/rheumatology/keac450
- By:
- Publication type:
- Article
Prognostic factors of systemic lupus erythematosus patients with pulmonary embolism: An 11-year cohort study.
- Published in:
- Lupus, 2022, v. 31, n. 7, p. 885, doi. 10.1177/09612033221095149
- By:
- Publication type:
- Article
Predicting the Risk of Pulmonary Arterial Hypertension in Systemic Lupus Erythematosus: A Chinese Systemic Lupus Erythematosus Treatment and Research Group Cohort Study.
- Published in:
- Arthritis & Rheumatology, 2021, v. 73, n. 10, p. 1847, doi. 10.1002/art.41740
- By:
- Publication type:
- Article
Evaluation of the Diagnostic Value of Non-criteria Antibodies for Antiphospholipid Syndrome Patients in a Chinese Cohort.
- Published in:
- Frontiers in Immunology, 2021, v. 12, p. 1, doi. 10.3389/fimmu.2021.741369
- By:
- Publication type:
- Article
Risk of osteonecrosis in systemic lupus erythematosus: An 11-year Chinese single-center cohort study.
- Published in:
- Lupus, 2021, v. 30, n. 9, p. 1459, doi. 10.1177/09612033211021166
- By:
- Publication type:
- Article
Comparison of Different Test Systems for the Detection of Antiphospholipid Antibodies in a Chinese Cohort.
- Published in:
- Frontiers in Immunology, 2021, v. 12, p. 1, doi. 10.3389/fimmu.2021.648881
- By:
- Publication type:
- Article
Tofacitinib as a possible treatment for skin thickening in diffuse cutaneous systemic sclerosis.
- Published in:
- Rheumatology, 2021, v. 60, n. 5, p. 2472, doi. 10.1093/rheumatology/keaa613
- By:
- Publication type:
- Article
Chinese SLE Treatment and Research Group Registry (CSTAR) XIII: prevalence and risk factors for chronic scarring alopecia in patients with systemic lupus erythematosus.
- Published in:
- Arthritis Research & Therapy, 2021, v. 23, n. 1, p. 1, doi. 10.1186/s13075-020-02407-5
- By:
- Publication type:
- Article
JAK Inhibitors: Prospects in Connective Tissue Diseases.
- Published in:
- Clinical Reviews in Allergy & Immunology, 2020, v. 59, n. 3, p. 334, doi. 10.1007/s12016-020-08786-6
- By:
- Publication type:
- Article
Clinical Characteristics of Systemic Lupus Erythematosus with Cirrhosis.
- Published in:
- 2020
- By:
- Publication type:
- journal article